BioCentury
ARTICLE | Finance

Results by market cap

October 6, 2008 7:00 AM UTC

Results by market cap The only market cap segment to post a positive gain in the third quarter were the biotechs valued at $500-$999 million. The mid-cap group was up 15% in 3Q08. In contrast, the...